- Home
- TCRX vs STEM Comparison
TCRX vs STEM Comparison
Compare TCRX & STEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCRX
- STEM
- Stock Information
- Founded
- TCRX 2018
- STEM 2009
- Country
- TCRX United States
- STEM United States
- Employees
- TCRX N/A
- STEM N/A
- Industry
- TCRX Biotechnology: Pharmaceutical Preparations
- STEM Computer Software: Prepackaged Software
- Sector
- TCRX Health Care
- STEM Technology
- Exchange
- TCRX Nasdaq
- STEM Nasdaq
- Market Cap
- TCRX 90.5M
- STEM 75.7M
- IPO Year
- TCRX 2021
- STEM N/A
- Fundamental
- Price
- TCRX $1.45
- STEM $0.49
- Analyst Decision
- TCRX Strong Buy
- STEM Hold
- Analyst Count
- TCRX 6
- STEM 9
- Target Price
- TCRX $9.50
- STEM $1.17
- AVG Volume (30 Days)
- TCRX 774.8K
- STEM 3.4M
- Earning Date
- TCRX 05-06-2025
- STEM 04-29-2025
- Dividend Yield
- TCRX N/A
- STEM N/A
- EPS Growth
- TCRX N/A
- STEM N/A
- EPS
- TCRX N/A
- STEM N/A
- Revenue
- TCRX $4,421,000.00
- STEM $151,627,000.00
- Revenue This Year
- TCRX $68.86
- STEM $5.72
- Revenue Next Year
- TCRX $14.01
- STEM $19.61
- P/E Ratio
- TCRX N/A
- STEM N/A
- Revenue Growth
- TCRX N/A
- STEM N/A
- 52 Week Low
- TCRX $1.02
- STEM $0.29
- 52 Week High
- TCRX $9.29
- STEM $1.68
- Technical
- Relative Strength Index (RSI)
- TCRX 49.42
- STEM 51.35
- Support Level
- TCRX $1.33
- STEM $0.35
- Resistance Level
- TCRX $1.49
- STEM $0.49
- Average True Range (ATR)
- TCRX 0.11
- STEM 0.05
- MACD
- TCRX 0.02
- STEM -0.01
- Stochastic Oscillator
- TCRX 69.12
- STEM 55.46
About TCRX TScan Therapeutics Inc.
TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.
About STEM Stem Inc.
Stem Inc is a provider of energy storage systems. The company bundles third-party hardware with its proprietary Athena software to provide customers a turnkey solution. Stem sells its solutions to commercial and industrial customers as well as independent power producers and renewable developers. Its solutions help customers maximize renewable energy generation and help build a cleaner and more resilient grid. The Company operates as one operating segment that is focused exclusively on technology services that transform the way energy is distributed and consumed.